PDLI Financial Facts
Total revenues: 91.85MNet income per diluted share (in dollars per share): 0.36
See Full Income Statement
Other assets: 4.93M
Cash and cash equivalents: 182.19M
See Full Balance Sheet
Earnings History for PDL BioPharma, Inc. (PDLI)
|
Expand Research on PDLI
| Next EPS Date | 5/3/12 | EPS Growth Rate | +4.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.0% | Revenue Growth Rate | -7.0% |
| Average % Move 1-Wk after EPS | +3.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/13  |
 |
Q113 | $0.36 | $0.35 | +$0.01 | $91.8M | $91.69M | N/A / N/A | N/A | +5.8% | Details |
| 3/1/13 |
|
Q412 | $0.34 | $0.32 | +$0.02 | $86M | $86.08M | N/A / N/A | N/A | +21.4% | Details |
| 11/5/12 |
|
Q312 | $0.32 | $0.30 | +$0.02 | $85.2M | $85.03M | N/A / N/A | N/A | +8.6% | Details |
| 8/2/12 |
|
Q212 | $0.53 | $0.49 | +$0.04 | $125.9M | $125.14M | $0.49 / $125.5M | N/A | +25% | Details |
| 5/3/12 |
|
Q112 | N/A | $0.26 | N/A | N/A | $77.47M | N/A / N/A | N/A | N/A | N/A |
| 2/23/12 |
|
Q411 | $0.24 | $0.24 | $0.00 | $72.81M | $72.85M | N/A / N/A | N/A | +30.5% | Details |
| 11/9/11 |
|
Q311 | $0.28 | $0.27 | +$0.01 | $83.8M | $82.85M | N/A / N/A | N/A | +40.6% | Details |
| 7/27/11 |
|
Q211 | $0.39 | $0.40 | -$0.01 | $122.1M | $123.25M | N/A / N/A | N/A | +35.1% | Details |
